Publications To Date


    Filter Publications

    PAGE 12 OF 87 | DISPLAYING 166 - 180 OF 1293 RESULTS

    Octeau D et al., Outcome-Related Differences in Gene Expression Profiles of High Grade Serous Ovarian Cancers Following Neoadjuvant Chemotherapy., , Mol Cancer Res, Sep 17, 2019

    Li C et al., The Transcription Factor Bhlhe40 Programs Mitochondrial Regulation of Resident CD8+ T Cell Fitness and Functionality, , Immunity., Sep 17, 2019

    Staiger AM et al., A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL., , Leukemia, Sep 17, 2019

    Park IH et al., Anti-tumor activity of BET inhibitors in androgen-receptor-expressing triple-negative breast cancer., , Sci Rep, Sep 16, 2019

    Li K et al., Preoperative Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with the Prognosis of Group 3 and Group 4 Medulloblastoma., , Sci Rep, Sep 13, 2019

    Penyige A et al., Circulating miRNA Profiling in Plasma Samples of Ovarian Cancer Patients., , Int J Mol Sci, Sep 13, 2019

    Haratani K et al., Clinical and immune profiling for cancer of unknown primary site., , J Immunother Cancer, Sep 13, 2019

    Roberto D et al., Functional validation of metabolic genes that distinguish Gleason 3 from Gleason 4 prostate cancer foci., , Prostate, Sep 10, 2019

    McQuerry et al., Pathway activity profiling of growth factor receptor network and stemness pathways differentiates metaplastic breast cancer histological subtypes, , BMC Cancer., Sep 10, 2019

    Dejene SB et al., Defining fallopian tube‐derived miRNA cancer signatures., , Cancer Med, Sep 10, 2019

    Jacquelot N et al., Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade., , Cell Res, Sep 03, 2019

    Zhang F et al., Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers., , Nat Commun, Sep 03, 2019

    kodama T et al., Anti-GPRC5D/CD3 Bispecific T-Cell–Redirecting Antibody for the Treatment of Multiple Myeloma, , Mol Cancer Ther, Sep 01, 2019

    Khalife J et al., MiR-16 regulates crosstalk in NF-κB tolerogenic inflammatory signaling between myeloma cells and bone marrow macrophages., , JCI Insight, Sep 01, 2019

    Tu B et al., YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma., , JCI Insight, Sep 01, 2019